- Clinical applications of functional imaging in oncology
- Fusion imaging: positron emission tomography, computed tomography, magnetic resonance imaging
- Novel radiopharmaceuticals targeting tumors
- Metabolic response assessment to therapy
Publisher Correction to: 18F-FDG PET/CT metabolic tumor parameters and radiomics features in aggressive non-Hodgkin's lymphoma as predictors of treatment outcome and survival.
Ann Nucl Med. 2018 Jun 20;:
718F-FDG PET/CT metabolic tumor parameters and radiomics features in aggressive non-Hodgkin's lymphoma as predictors of treatment outcome and survival.
Ann Nucl Med. 2018 May 12;:
Measurement of Tumor Hypoxia in Patients With Locally Advanced Cervical Cancer Using Positron Emission Tomography with 18F-Fluoroazomyin Arabinoside.
Int J Radiat Oncol Biol Phys. 2018 Mar 02;:
18F-FDG PET/CT in the management of patients with malignant pleural mesothelioma being considered for multimodality therapy: experience of a tertiary referral center.
Br J Radiol. 2018 Mar 02;:20170814
Neoadjuvant hyperfractionated chemoradiation and liver transplantation for unresectable perihilar cholangiocarcinoma in Canada.
J Surg Oncol. 2018 Feb;117(2):213-219
Administration of Hypoxia-Activated Prodrug Evofosfamide after Adjuvant Therapy Enhances Therapeutic Outcome and Targets Cancer-Initiating Cells in Colorectal Cancer.
Clin Cancer Res. 2018 Feb 23;:
AJR Am J Roentgenol. 2018 Jan 11;:1-6
Indian J Radiol Imaging. 2017 Apr-Jun;27(2):167-176
Semin Nucl Med. 2017 Jul;47(4):352-361
Ann Nucl Med. 2017 Mar 28;:
Core Lead, Techna Institute for the Advancement of Technology for Health (Techna)
Cancer Clinical Research Unit (CCRU), Princess Margaret Cancer Centre
Associate Professor, Department of Medical Imaging, University of Toronto